Note 10 - Warrants to Purchase Common Stock |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Outstanding Warrants [Text Block] |
10. Warrants to Purchase Common Stock
On June 30, 2026, the maturity dates on two accredited investors' Subordinated Notes were extended to December 31, 2026. In connection with the extension, we granted the noteholders warrants exercisable for the purchase of 113 thousand shares of Aemetis, Inc. common stock with a term of years and an exercise price of $0.01 per share. The warrants were fully exercised by the noteholders in July 2026.
The following table summarizes warrant activity during the six months ending June 30, 2026:
All of the above outstanding warrants are fully vested and exercisable as of June 30, 2026.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||